Thiazolidinediones are peroxisome proliferator-activated receptor-γ (PPARγ) agonists used as insulin-sensitising drugs for the treatment of T2DM, although adverse side effects have reduced their use substantially (134). Here, INS is linked to type 2 diabetes mellitus.